UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline Update

Journal of clinical oncology, 2017-12, Vol.35 (35), p.3978-3986

2017

Volltextzugriff (PDF)

Statin therapy in the treatment of active cancer: A systematic review and meta-analysis of randomized controlled trials

PloS one, 2018-12, Vol.13 (12), p.e0209486-e0209486

2018

Volltextzugriff (PDF)

Screening for osteoporosis in postmenopausal women with breast cancer receiving aromatase inhibitors: less is more?

Journal of clinical oncology, 2012-05, Vol.30 (13), p.1408-1410

Dhesy-Thind, Sukhbinder K

2012

Volltextzugriff (PDF)

Thyroid hormone receptor α in breast cancer: prognostic and therapeutic implications

Breast cancer research and treatment, 2015-01, Vol.149 (1), p.293-301

2015

Volltextzugriff (PDF)

Canadian Institutes of Health Research dissemination grant on high-sensitivity cardiac troponin

Clinical biochemistry, 2014-11, Vol.47 (16-17), p.155-157

2014

Volltextzugriff (PDF)

Targeted metabolomics in colorectal cancer: a strategic approach using standardized laboratory tests of the blood and urine

Hypoxia, 2017-01, Vol.5, p.61-66

2017

Volltextzugriff (PDF)

Recurrence score gene axes scores and outcomes by race and ethnicity in the RxPONDER trial

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.515-515

2024

Volltextzugriff (PDF)

The ESCAPADE Study: Early supportive care for advanced cancer patients, assessing care delivery and provider engagement

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e23142-e23142

2019

Volltextzugriff (PDF)

Code status communication training in Canadian postgraduate oncology programs: A needs assessment survey

Journal of clinical oncology, 2017-11, Vol.35 (31_suppl), p.13-13

2017

Volltextzugriff (PDF)

The PULSES project: Teaching the vital elements of code status discussions to oncology residents

Journal of clinical oncology, 2017-11, Vol.35 (31_suppl), p.46-46

2017

Volltextzugriff (PDF)

Prognostic potential of thyroid receptor TRα2 in breast cancer

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e11535-e11535

2014

Volltextzugriff (PDF)

Rates of trastuzumab-associated cardiotoxicity in patients with HER2-positive breast cancer at a tertiary cancer centre

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e12030-e12030

2017

Volltextzugriff (PDF)

The PULSES project: Teaching the vital elements of code status discussions to oncology residents

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.10024-10024

2017

Volltextzugriff (PDF)

Evaluation of the safety of continuing trastuzumab despite overt left ventricular dysfunction

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e18548-e18548

2018

Volltextzugriff (PDF)

Abstract 3787: Thyroid hormone induced proliferation of breast cancer cell lines: A novel approach to hormone therapy

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.3787-3787

2016

Volltextzugriff (PDF)

Blood and urine markers of metabolic dysfunction in colorectal cancer: a pilot study

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e14611-e14611

2015

Volltextzugriff (PDF)

Abstract CT131: A randomized (RCT) phase II study of oncolytic reovirus (pelareorep ) plus standard weekly paclitaxel (P) as therapy for metastatic breast cancer (mBC)

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.CT131-CT131

2017

Volltextzugriff (PDF)

Expression of thyroid hormone receptor alpha (THRα) isoforms in triple negative breast cancer (TNBC)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e12082-e12082

2015

Volltextzugriff (PDF)

Thyroid hormone receptor [alpha] in breast cancer: prognostic and therapeutic implications

Breast cancer research and treatment, 2015-01, Vol.149 (1), p.293

2015

Volltextzugriff (PDF)

Rapid assessment of frailty prior to treatment of elderly colorectal cancer patients

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e20522-e20522

2013

Volltextzugriff (PDF)

PANCREOX: A randomized phase 3 study of 5FU/LV with or without oxaliplatin for second-line advanced pancreatic cancer (APC) in patients (pts) who have received gemcitabine (GEM)-based chemotherapy (CT)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.4022-4022

2014

Volltextzugriff (PDF)

Utility of the Edmonton Frail Scale (EFS) in identifying frail elderly patients during treatment of colorectal cancer (CRC)

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e14001-e14001

2012

Volltextzugriff (PDF)

Positron emission tomography/computed tomography (PET/CT) for the diagnosis of recurrent cancer (PETREC): A multicenter, prospective cohort study

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.6049-6049

2012

Volltextzugriff (PDF)

Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update

Journal of clinical oncology, 2022-03, Vol.40 (7), p.787-800

2022

Volltextzugriff (PDF)

Abstract GS2-07: Updated results from a phase 3 randomized clinical trial in participants (pts) with 1-3 positive lymph nodes (LN), hormone receptor-positive (HR+) and HER2-negative (HER2-) breast cancer (BC) with recurrence score (RS) ≤ 25 randomized to endocrine therapy (ET) +/- chemotherapy (CT): SWOG S1007 (RxPONDER)

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.GS2-07-GS2-07

2022

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)

Erscheinungsjahr

n.n

Thema

Science & Technology
(8)
Life Sciences & Biomedicine
(7)
Humans
(6)
Female
(5)
Oncology
(4)
Bone Density Conservation Agents - Therapeutic Use
(3)
Breast Neoplasms - Drug Therapy
(3)
Breast Neoplasms - Pathology
(3)
Diphosphonates - Therapeutic Use
(3)
Prognosis
(3)
Randomized Controlled Trials As Topic
(3)
Adult
(2)
Aged
(2)
Analysis
(2)
Biomarkers
(2)
Bone Neoplasms - Secondary
(2)
Breast Cancer
(2)
Cancer
(2)
Cancer Therapies
(2)
Clinical Trials, Phase Iii As Topic
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(17)
Cancer Research
(4)
Breast Cancer Research And Treatment
(2)
Clinica Chimica Acta
(1)
Clinical Biochemistry
(1)
Hypoxia
(1)
Plos One
(1)

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline Update

Statin therapy in the treatment of active cancer: A systematic review and meta-analysis of randomized controlled trials

Screening for osteoporosis in postmenopausal women with breast cancer receiving aromatase inhibitors: less is more?

Thyroid hormone receptor α in breast cancer: prognostic and therapeutic implications

Canadian Institutes of Health Research dissemination grant on high-sensitivity cardiac troponin

Targeted metabolomics in colorectal cancer: a strategic approach using standardized laboratory tests of the blood and urine

Recurrence score gene axes scores and outcomes by race and ethnicity in the RxPONDER trial

The ESCAPADE Study: Early supportive care for advanced cancer patients, assessing care delivery and provider engagement

Code status communication training in Canadian postgraduate oncology programs: A needs assessment survey

The PULSES project: Teaching the vital elements of code status discussions to oncology residents

Prognostic potential of thyroid receptor TRα2 in breast cancer

Rates of trastuzumab-associated cardiotoxicity in patients with HER2-positive breast cancer at a tertiary cancer centre

The PULSES project: Teaching the vital elements of code status discussions to oncology residents

Evaluation of the safety of continuing trastuzumab despite overt left ventricular dysfunction

Abstract 3787: Thyroid hormone induced proliferation of breast cancer cell lines: A novel approach to hormone therapy

Blood and urine markers of metabolic dysfunction in colorectal cancer: a pilot study

Abstract CT131: A randomized (RCT) phase II study of oncolytic reovirus (pelareorep ) plus standard weekly paclitaxel (P) as therapy for metastatic breast cancer (mBC)

Expression of thyroid hormone receptor alpha (THRα) isoforms in triple negative breast cancer (TNBC)

Thyroid hormone receptor [alpha] in breast cancer: prognostic and therapeutic implications

Rapid assessment of frailty prior to treatment of elderly colorectal cancer patients

PANCREOX: A randomized phase 3 study of 5FU/LV with or without oxaliplatin for second-line advanced pancreatic cancer (APC) in patients (pts) who have received gemcitabine (GEM)-based chemotherapy (CT)

Utility of the Edmonton Frail Scale (EFS) in identifying frail elderly patients during treatment of colorectal cancer (CRC)

Positron emission tomography/computed tomography (PET/CT) for the diagnosis of recurrent cancer (PETREC): A multicenter, prospective cohort study

Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update

Suchergebnisse filtern